MyAverix Finance
US · Healthcare
Cingulate Inc (CING)
Biotechnology
Cingulate Inc (CING) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CING
Cingulate Inc (CING) — FAQ
What is CING's P/E ratio?
The price-to-earnings (P/E) ratio for Cingulate Inc (CING) is 25.00 (data as of 2026-05-23).
Does Cingulate Inc pay a dividend?
Dividend yield is not available in the current snapshot for Cingulate Inc (CING). Check the MyAverix Finance app for the latest dividend data.
What sector is Cingulate Inc in?
Cingulate Inc (CING) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CING listed on?
CING is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.